These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2644825)

  • 21. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physiopathology of lipoprotein glomerulopathy].
    Saito T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1838-44. PubMed ID: 17037324
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonamyloidotic fibrillary glomerulopathy, immunotactoid glomerulopathy, and the differential diagnosis of filamentous glomerulopathies.
    Devaney K; Sabnis SG; Antonovych TT
    Mod Pathol; 1991 Jan; 4(1):36-45. PubMed ID: 2020659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of the glomerulopathy associated with renal infarction in rats.
    Purkerson ML; Hoffsten PE; Klahr S
    Kidney Int; 1976 May; 9(5):407-17. PubMed ID: 940276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glomerular capillary tenascin staining in renal allografts and its correlation with capillary loop 'double contours', proteinuria and graft outcome.
    Fukuda M; Morozumi K; Uchida K; Oikawa T; Takeda A; Yosida A; Kimura G
    Nephron Clin Pract; 2004; 96(4):c115-22. PubMed ID: 15122065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.
    Boumendjel R; Papari M; Gonzalez M
    Arch Pathol Lab Med; 2010 Feb; 134(2):279-82. PubMed ID: 20121619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collapsing glomerulopathy: a cause of noncardiogenic pulmonary edema.
    Wiederkehr MR; Rogers TE; Moe OW
    Am J Kidney Dis; 2002 Sep; 40(3):E10. PubMed ID: 12200827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy.
    Konishi K; Saruta T; Kuramochi S; Oikawa S; Saito T; Han H; Matsunaga A; Sasaki J
    Nephron; 1999; 83(3):214-8. PubMed ID: 10529627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
    Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
    Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy.
    Ieiri N; Hotta O; Taguma Y
    Am J Kidney Dis; 2003 Jan; 41(1):244-9. PubMed ID: 12500244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathologic features of collagen III glomerulopathy].
    Liu H; Chen J; Zhang Y; Wang S; Zou W
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):732-5. PubMed ID: 25582250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis.
    Watanabe Y; Ozaki I; Yoshida F; Fukatsu A; Itoh Y; Matsuo S; Sakamoto N
    Nephron; 1989; 51(2):265-70. PubMed ID: 2644575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glomerular capillary light chain thrombi in multiple myeloma.
    Kurita N; Tanaka M; Tanaka S; Fujii A; Sugimoto T; Yamaguchi Y; Mise N
    Kidney Int; 2011 Dec; 80(12):1378. PubMed ID: 22126985
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.
    Cambruzzi E; Pêgas KL
    J Bras Nefrol; 2019; 41(3):393-399. PubMed ID: 30421781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal lipid metabolism and renal disorders.
    Saito T
    Tohoku J Exp Med; 1997 Mar; 181(3):321-37. PubMed ID: 9163848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first case of lipoprotein glomerulopathy complicated with collagen type III glomerulopathy and literature review.
    Liu H; Luo C; Li Z; Zhang C; Xiong J
    J Nephrol; 2023 Apr; 36(3):663-667. PubMed ID: 36370330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the avian polyomavirus-associated glomerulopathy of nestling parrots.
    Phalen DN; Wilson VG; Graham DL
    Avian Dis; 1996; 40(1):140-9. PubMed ID: 8713028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipoprotein glomerulopathy: a novel glomerular disease presenting with peculiar morphological findings].
    Nihon Jinzo Gakkai Shi; 1989 May; 31(5):451-6. PubMed ID: 2622077
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.
    Karube M; Nakabayashi K; Fujioka Y; Yoshihara K; Yamada A; Matsunaga A; Saito T
    Clin Exp Nephrol; 2007 Jun; 11(2):174-179. PubMed ID: 17593519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.